Annual Total Long Term Liabilities
$254.90 M
+$6.78 M+2.73%
December 1, 2023
Summary
- As of February 8, 2025, ARTV annual total long term liabilities is $254.90 million, with the most recent change of +$6.78 million (+2.73%) on December 1, 2023.
- During the last 3 years, ARTV annual total long term liabilities has risen by +$209.87 million (+465.98%).
- ARTV annual total long term liabilities is now at all-time high.
Performance
ARTV Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$11.31 M
-$244.87 M-95.59%
September 1, 2024
Summary
- As of February 8, 2025, ARTV quarterly total long term liabilities is $11.31 million, with the most recent change of -$244.87 million (-95.59%) on September 1, 2024.
- ARTV quarterly long term liabilities is now -95.59% below its all-time high of $256.18 million, reached on June 1, 2024.
Performance
ARTV Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
ARTV Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.7% | - |
| 3 y3 years | +466.0% | - |
| 5 y5 years | +3144.3% | - |
ARTV Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +6.4% | -95.6% | at low |
| 5 y | 5-year | at high | +3144.3% | -95.6% | at low |
| alltime | all time | at high | +3144.3% | -95.6% | at low |
Artiva Biotherapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $11.31 M(-95.6%) |
| Jun 2024 | - | $256.18 M(+0.7%) |
| Mar 2024 | - | $254.47 M(-0.2%) |
| Dec 2023 | $254.90 M(+2.7%) | $254.90 M(+6.8%) |
| Dec 2022 | $248.13 M | - |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $238.62 M(-0.4%) |
| Dec 2021 | $239.48 M(+431.7%) | $239.48 M(-1.0%) |
| Sep 2021 | - | $241.83 M(+437.0%) |
| Dec 2020 | $45.04 M(+473.2%) | $45.04 M |
| Dec 2019 | $7.86 M | - |
FAQ
- What is Artiva Biotherapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Artiva Biotherapeutics?
- What is Artiva Biotherapeutics annual total long term liabilities year-on-year change?
- What is Artiva Biotherapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Artiva Biotherapeutics?
What is Artiva Biotherapeutics annual total long term liabilities?
The current annual total long term liabilities of ARTV is $254.90 M
What is the all time high annual total long term liabilities for Artiva Biotherapeutics?
Artiva Biotherapeutics all-time high annual total long term liabilities is $254.90 M
What is Artiva Biotherapeutics annual total long term liabilities year-on-year change?
Over the past year, ARTV annual total long term liabilities has changed by +$6.78 M (+2.73%)
What is Artiva Biotherapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of ARTV is $11.31 M
What is the all time high quarterly long term liabilities for Artiva Biotherapeutics?
Artiva Biotherapeutics all-time high quarterly total long term liabilities is $256.18 M